Arbutus Biopharma ABUS
NASDAQ ABUS
$3.83 +0.11 (+2.82%)
As of: Nov 10, 2026 · 3:59 PM EST

Arbutus Biopharma (ABUS) Equity Income (2018 - 2020)

Updated

Arbutus Biopharma (ABUS) recorded Equity Income of -$2.55 million in FY2020, compared with -$22.52 million in FY2019.

Analysis

Arbutus Biopharma (ABUS) Equity Income (2018 - 2020) Analysis & Trends

  • Per Business Quant data, ABUS's Equity Income was -$22.52 million in FY2019 and -$5.56 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn -
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -10.00 Mn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn -
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn -
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Arbutus Biopharma 755.33 Mn 382.30 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 -2.55 Mn
Dec 31, 2019 -11.03 Mn
Sep 30, 2019 -3.51 Mn
Jun 30, 2019 -3.33 Mn
Mar 31, 2019 -4.65 Mn
Dec 31, 2018 -2.72 Mn
Sep 30, 2018 -2.84 Mn
API Access

Arbutus Biopharma Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=ABUS&period=max&api_key=YOUR_API_KEY